第二型糖尿病的全球市場 2023-2027

這份報告提供第二型糖尿病的市場規模在2023年～2027年間，預測將成長到393億7000萬美元，在預測期間內預計將以10.94％的年複合成長率增長。本報告提供第二型糖尿病市場整體分析，提供市場規模·預測，趨勢，成長促進因素·課題，再加上約25家供應商的供應商分析等資訊。

同時本報告還提供當前全球市場趨勢與推動因素以及整體市場環境的最新分析。

市場成長的主要因素有糖尿病的盛行率上升，肥胖的盛行率上升和生活方式的變化，及最近的產品認證。

目錄

第1章 摘要整理

• 市場概要

第2章 市場形勢

• 市場生態系統

第3章 市場規模

• 市場定義
• 市場區隔分析
• 市場規模 2022
• 市場預測:2022-2027年的預測

第4章 市場規模實際成果

• 全球第二型糖尿病市場2017～2021年
• 醫藥品分類市場區隔分析2017-2021
• 流通管道市場區隔分析2017-2021
• 地區市場區隔分析2017-2021
• 國家市場區隔分析2017-2021

第5章 波特的五力分析

• 五力的摘要
• 買方議價能力
• 供給企業談判力
• 新加入廠商業者的威脅
• 替代品的威脅
• 競爭的威脅
• 市場情況

第6章 各藥物類別市場區隔

• 市場明細
• 各類藥物比較
• 胰島素 - 市場規模與預測 2022-2027
• DPP-4抑制劑 - 市場規模與預測 2022-2027
• GLP-1受體促效劑 - 市場規模與預測 2022-2027
• SGLT-2抑制劑 - 市場規模與預測 2022-2027
• 其他 - 市場規模與預測 2022-2027
• 各醫藥品分類的市場機會

第7章 各流通管道市場區隔

• 市場明細
• 各流通管道比較
• 零售藥局 - 市場規模與預測 2022-2027
• 醫院藥局 - 市場規模與預測 2022-2027
• 線上藥局 - 市場規模與預測 2022-2027
• 各流通管道的市場機會

第8章 客戶形勢

• 客戶形勢概要

第9章 各地區形勢

• 各地區市場區隔
• 各地區比較
• 北美 - 市場規模與預測 2022-2027
• 歐洲 - 市場規模與預測 2022-2027
• 亞洲 - 市場規模與預測 2022-2027
• 其他地區(ROW) - 市場規模與預測 2022-2027
• 美國 - 市場規模與預測 2022-2027
• 德國 - 市場規模與預測 2022-2027
• 中國 - 市場規模與預測 2022-2027
• 英國 - 市場規模與預測 2022-2027
• 印度 - 市場規模與預測 2022-2027
• 各地區的市場機會

第10章 促進因素，課題，及趨勢

• 推動市場要素
• 市場課題
• 推動因素與課題的影響
• 市場趨勢

第11章 業者情勢

• 概要
• 業者情勢
• 混亂狀況
• 產業的風險

第12章 供應商分析

• 交易廠商
• 供應商的市場定位
• Amgen Inc.
• AstraZeneca Plc
• Biocon Ltd.
• Boehringer Ingelheim International GmbH
• Cadila Pharmaceuticals Ltd.
• Daiichi Sankyo Co. Ltd.
• Eli Lilly and Co.
• Glenmark Pharmaceuticals Ltd.
• Merck KGaA
• Novartis AG
• Novo Nordisk AS
• Pfizer Inc.
• Sanofi SA
• Takeda Pharmaceutical Co. Ltd.
• Tonghua Dongbao Pharmaceutical Co. Ltd.

第13章 附錄

Technavio has been monitoring the type 2 diabetes market and it is poised to grow by $39.37 bn during 2023-2027, accelerating at a CAGR of 10.94% during the forecast period. Our report on the type 2 diabetes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of diabetes, irse in prevalence of obesity and changing lifestyles, and recent product approvals.

Technavio's type 2 diabetes market is segmented as below:

By Drug Class

• Insulin
• DPP-4 inhibitor
• GLP-1 receptor agonists
• SGLT-2 inhibitors
• Others

By Distribution Channel

• Retail pharmacies
• Hospital pharmacies
• Online pharmacies

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing geriatric population as one of the prime reasons driving the type 2 diabetes market growth during the next few years. Also, an increase in awareness of diabetes and growth initiatives and innovations in therapies will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the type 2 diabetes market covers the following areas:

• Type 2 diabetes market sizing
• Type 2 diabetes market forecast
• Type 2 diabetes market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading type 2 diabetes market vendors that include Amgen Inc., AstraZeneca Plc, Baxter International Inc., Biocon Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Daiichi Sankyo Co. Ltd., DM Pharma Marketing Pvt. Ltd., Eli Lilly and Co., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Johnson and Johnson, Merck KGaA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Practo Technologies Pvt. Ltd., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Tonghua Dongbao Pharmaceutical Co. Ltd. Also, the type 2 diabetes market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market by Geography
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Drug Class
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global type 2 diabetes market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global type 2 diabetes market 2017 - 2021 ($ billion)
• 4.2 Drug class Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Drug class Segment 2017 - 2021 ($ billion)
• 4.3 Distribution channel Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ billion)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Drug Class

• 6.1 Market segments
• Exhibit 30: Chart on Drug Class - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Drug Class - Market share 2022-2027 (%)
• 6.2 Comparison by Drug Class
• Exhibit 32: Chart on Comparison by Drug Class
• Exhibit 33: Data Table on Comparison by Drug Class
• 6.3 Insulin - Market size and forecast 2022-2027
• Exhibit 34: Chart on Insulin - Market size and forecast 2022-2027 ($ billion)
• Exhibit 35: Data Table on Insulin - Market size and forecast 2022-2027 ($ billion)
• Exhibit 36: Chart on Insulin - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Insulin - Year-over-year growth 2022-2027 (%)
• 6.4 DPP-4 inhibitor - Market size and forecast 2022-2027
• Exhibit 38: Chart on DPP-4 inhibitor - Market size and forecast 2022-2027 ($ billion)
• Exhibit 39: Data Table on DPP-4 inhibitor - Market size and forecast 2022-2027 ($ billion)
• Exhibit 40: Chart on DPP-4 inhibitor - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on DPP-4 inhibitor - Year-over-year growth 2022-2027 (%)
• 6.5 GLP-1 receptor agonists - Market size and forecast 2022-2027
• Exhibit 42: Chart on GLP-1 receptor agonists - Market size and forecast 2022-2027 ($ billion)
• Exhibit 43: Data Table on GLP-1 receptor agonists - Market size and forecast 2022-2027 ($ billion)
• Exhibit 44: Chart on GLP-1 receptor agonists - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on GLP-1 receptor agonists - Year-over-year growth 2022-2027 (%)
• 6.6 SGLT-2 inhibitors - Market size and forecast 2022-2027
• Exhibit 46: Chart on SGLT-2 inhibitors - Market size and forecast 2022-2027 ($ billion)
• Exhibit 47: Data Table on SGLT-2 inhibitors - Market size and forecast 2022-2027 ($ billion)
• Exhibit 48: Chart on SGLT-2 inhibitors - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on SGLT-2 inhibitors - Year-over-year growth 2022-2027 (%)
• 6.7 Others - Market size and forecast 2022-2027
• Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 6.8 Market opportunity by Drug Class
• Exhibit 54: Market opportunity by Drug Class ($ billion)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
• Exhibit 55: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibit 56: Data Table on Distribution Channel - Market share 2022-2027 (%)
• 7.2 Comparison by Distribution Channel
• Exhibit 57: Chart on Comparison by Distribution Channel
• Exhibit 58: Data Table on Comparison by Distribution Channel
• 7.3 Retail pharmacies - Market size and forecast 2022-2027
• Exhibit 59: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 60: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 61: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
• 7.4 Hospital pharmacies - Market size and forecast 2022-2027
• Exhibit 63: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 64: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 65: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
• 7.5 Online pharmacies - Market size and forecast 2022-2027
• Exhibit 67: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 68: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 69: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
• 7.6 Market opportunity by Distribution Channel
• Exhibit 71: Market opportunity by Distribution Channel ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 73: Chart on Market share by geography 2022-2027 (%)
• Exhibit 74: Data Table on Market share by geography 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 75: Chart on Geographic comparison
• Exhibit 76: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 77: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 78: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 79: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 81: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 82: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 85: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 86: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 87: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 93: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 94: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 95: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.9 China - Market size and forecast 2022-2027
• Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.10 UK - Market size and forecast 2022-2027
• Exhibit 105: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 106: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 107: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 108: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.11 India - Market size and forecast 2022-2027
• Exhibit 109: Chart on India - Market size and forecast 2022-2027 ($ billion)
• Exhibit 110: Data Table on India - Market size and forecast 2022-2027 ($ billion)
• Exhibit 111: Chart on India - Year-over-year growth 2022-2027 (%)
• Exhibit 112: Data Table on India - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity by geography
• Exhibit 113: Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 114: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 116: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 117: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 118: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 119: Matrix on vendor position and classification
• 12.3 Amgen Inc.
• Exhibit 120: Amgen Inc. - Overview
• Exhibit 121: Amgen Inc. - Product / Service
• Exhibit 122: Amgen Inc. - Key offerings
• 12.4 AstraZeneca Plc
• Exhibit 123: AstraZeneca Plc - Overview
• Exhibit 124: AstraZeneca Plc - Product / Service
• Exhibit 125: AstraZeneca Plc - Key news
• Exhibit 126: AstraZeneca Plc - Key offerings
• 12.5 Biocon Ltd.
• Exhibit 127: Biocon Ltd. - Overview
• Exhibit 128: Biocon Ltd. - Business segments
• Exhibit 129: Biocon Ltd. - Key offerings
• Exhibit 130: Biocon Ltd. - Segment focus
• 12.6 Boehringer Ingelheim International GmbH
• Exhibit 131: Boehringer Ingelheim International GmbH - Overview
• Exhibit 132: Boehringer Ingelheim International GmbH - Business segments
• Exhibit 133: Boehringer Ingelheim International GmbH - Key news
• Exhibit 134: Boehringer Ingelheim International GmbH - Key offerings
• Exhibit 135: Boehringer Ingelheim International GmbH - Segment focus
• 12.7 Cadila Pharmaceuticals Ltd.
• Exhibit 136: Cadila Pharmaceuticals Ltd. - Overview
• Exhibit 137: Cadila Pharmaceuticals Ltd. - Product / Service
• Exhibit 138: Cadila Pharmaceuticals Ltd. - Key offerings
• 12.8 Daiichi Sankyo Co. Ltd.
• Exhibit 139: Daiichi Sankyo Co. Ltd. - Overview
• Exhibit 140: Daiichi Sankyo Co. Ltd. - Business segments
• Exhibit 141: Daiichi Sankyo Co. Ltd. - Key news
• Exhibit 142: Daiichi Sankyo Co. Ltd. - Key offerings
• Exhibit 143: Daiichi Sankyo Co. Ltd. - Segment focus
• 12.9 Eli Lilly and Co.
• Exhibit 144: Eli Lilly and Co. - Overview
• Exhibit 145: Eli Lilly and Co. - Product / Service
• Exhibit 146: Eli Lilly and Co. - Key offerings
• 12.10 Glenmark Pharmaceuticals Ltd.
• Exhibit 147: Glenmark Pharmaceuticals Ltd. - Overview
• Exhibit 148: Glenmark Pharmaceuticals Ltd. - Product / Service
• Exhibit 149: Glenmark Pharmaceuticals Ltd. - Key offerings
• 12.11 Merck KGaA
• Exhibit 150: Merck KGaA - Overview
• Exhibit 151: Merck KGaA - Business segments
• Exhibit 152: Merck KGaA - Key news
• Exhibit 153: Merck KGaA - Key offerings
• Exhibit 154: Merck KGaA - Segment focus
• 12.12 Novartis AG
• Exhibit 155: Novartis AG - Overview
• Exhibit 156: Novartis AG - Business segments
• Exhibit 157: Novartis AG - Key offerings
• Exhibit 158: Novartis AG - Segment focus
• 12.13 Novo Nordisk AS
• Exhibit 159: Novo Nordisk AS - Overview
• Exhibit 160: Novo Nordisk AS - Business segments
• Exhibit 161: Novo Nordisk AS - Key offerings
• Exhibit 162: Novo Nordisk AS - Segment focus
• 12.14 Pfizer Inc.
• Exhibit 163: Pfizer Inc. - Overview
• Exhibit 164: Pfizer Inc. - Product / Service
• Exhibit 165: Pfizer Inc. - Key news
• Exhibit 166: Pfizer Inc. - Key offerings
• 12.15 Sanofi SA
• Exhibit 167: Sanofi SA - Overview
• Exhibit 168: Sanofi SA - Business segments
• Exhibit 169: Sanofi SA - Key news
• Exhibit 170: Sanofi SA - Key offerings
• Exhibit 171: Sanofi SA - Segment focus
• 12.16 Takeda Pharmaceutical Co. Ltd.
• Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 173: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 174: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 175: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 12.17 Tonghua Dongbao Pharmaceutical Co. Ltd.
• Exhibit 176: Tonghua Dongbao Pharmaceutical Co. Ltd. - Overview
• Exhibit 177: Tonghua Dongbao Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 178: Tonghua Dongbao Pharmaceutical Co. Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 179: Inclusions checklist
• Exhibit 180: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 181: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 182: Research methodology
• Exhibit 183: Validation techniques employed for market sizing
• Exhibit 184: Information sources
• 13.5 List of abbreviations
• Exhibit 185: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market by Geography
• Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
• Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global type 2 diabetes market 2017 - 2021 ($ billion)
• Exhibits19: Historic Market Size - Drug class Segment 2017 - 2021 ($ billion)
• Exhibits20: Historic Market Size - Distribution channel Segment 2017 - 2021 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Drug Class - Market share 2022-2027 (%)
• Exhibits31: Data Table on Drug Class - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Drug Class
• Exhibits33: Data Table on Comparison by Drug Class
• Exhibits34: Chart on Insulin - Market size and forecast 2022-2027 ($ billion)
• Exhibits35: Data Table on Insulin - Market size and forecast 2022-2027 ($ billion)
• Exhibits36: Chart on Insulin - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Insulin - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on DPP-4 inhibitor - Market size and forecast 2022-2027 ($ billion)
• Exhibits39: Data Table on DPP-4 inhibitor - Market size and forecast 2022-2027 ($ billion)
• Exhibits40: Chart on DPP-4 inhibitor - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on DPP-4 inhibitor - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on GLP-1 receptor agonists - Market size and forecast 2022-2027 ($ billion)
• Exhibits43: Data Table on GLP-1 receptor agonists - Market size and forecast 2022-2027 ($ billion)
• Exhibits44: Chart on GLP-1 receptor agonists - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on GLP-1 receptor agonists - Year-over-year growth 2022-2027 (%)
• Exhibits46: Chart on SGLT-2 inhibitors - Market size and forecast 2022-2027 ($ billion)
• Exhibits47: Data Table on SGLT-2 inhibitors - Market size and forecast 2022-2027 ($ billion)
• Exhibits48: Chart on SGLT-2 inhibitors - Year-over-year growth 2022-2027 (%)
• Exhibits49: Data Table on SGLT-2 inhibitors - Year-over-year growth 2022-2027 (%)
• Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits54: Market opportunity by Drug Class ($ billion)
• Exhibits55: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibits56: Data Table on Distribution Channel - Market share 2022-2027 (%)
• Exhibits57: Chart on Comparison by Distribution Channel
• Exhibits58: Data Table on Comparison by Distribution Channel
• Exhibits59: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibits60: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibits61: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits62: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits63: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibits64: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibits65: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits66: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits67: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibits68: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
• Exhibits69: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits70: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
• Exhibits71: Market opportunity by Distribution Channel ($ billion)
• Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits73: Chart on Market share by geography 2022-2027 (%)
• Exhibits74: Data Table on Market share by geography 2022-2027 (%)
• Exhibits75: Chart on Geographic comparison
• Exhibits76: Data Table on Geographic comparison
• Exhibits77: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibits78: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibits79: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits80: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits81: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibits82: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibits83: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits85: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibits86: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibits87: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits93: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibits94: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibits95: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits96: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits97: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibits98: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibits99: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits101: Chart on China - Market size and forecast 2022-2027 ($ billion)
• Exhibits102: Data Table on China - Market size and forecast 2022-2027 ($ billion)
• Exhibits103: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits104: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits105: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibits106: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibits107: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits108: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits109: Chart on India - Market size and forecast 2022-2027 ($ billion)
• Exhibits110: Data Table on India - Market size and forecast 2022-2027 ($ billion)
• Exhibits111: Chart on India - Year-over-year growth 2022-2027 (%)
• Exhibits112: Data Table on India - Year-over-year growth 2022-2027 (%)
• Exhibits113: Market opportunity by geography ($ billion)
• Exhibits114: Impact of drivers and challenges in 2022 and 2027
• Exhibits115: Overview on Criticality of inputs and Factors of differentiation
• Exhibits116: Overview on factors of disruption
• Exhibits117: Impact of key risks on business
• Exhibits118: Vendors covered
• Exhibits119: Matrix on vendor position and classification
• Exhibits120: Amgen Inc. - Overview
• Exhibits121: Amgen Inc. - Product / Service
• Exhibits122: Amgen Inc. - Key offerings
• Exhibits123: AstraZeneca Plc - Overview
• Exhibits124: AstraZeneca Plc - Product / Service
• Exhibits125: AstraZeneca Plc - Key news
• Exhibits126: AstraZeneca Plc - Key offerings
• Exhibits127: Biocon Ltd. - Overview
• Exhibits128: Biocon Ltd. - Business segments
• Exhibits129: Biocon Ltd. - Key offerings
• Exhibits130: Biocon Ltd. - Segment focus
• Exhibits131: Boehringer Ingelheim International GmbH - Overview
• Exhibits132: Boehringer Ingelheim International GmbH - Business segments
• Exhibits133: Boehringer Ingelheim International GmbH - Key news
• Exhibits134: Boehringer Ingelheim International GmbH - Key offerings
• Exhibits135: Boehringer Ingelheim International GmbH - Segment focus
• Exhibits136: Cadila Pharmaceuticals Ltd. - Overview
• Exhibits137: Cadila Pharmaceuticals Ltd. - Product / Service
• Exhibits138: Cadila Pharmaceuticals Ltd. - Key offerings
• Exhibits139: Daiichi Sankyo Co. Ltd. - Overview
• Exhibits140: Daiichi Sankyo Co. Ltd. - Business segments
• Exhibits141: Daiichi Sankyo Co. Ltd. - Key news
• Exhibits142: Daiichi Sankyo Co. Ltd. - Key offerings
• Exhibits143: Daiichi Sankyo Co. Ltd. - Segment focus
• Exhibits144: Eli Lilly and Co. - Overview
• Exhibits145: Eli Lilly and Co. - Product / Service
• Exhibits146: Eli Lilly and Co. - Key offerings
• Exhibits147: Glenmark Pharmaceuticals Ltd. - Overview
• Exhibits148: Glenmark Pharmaceuticals Ltd. - Product / Service
• Exhibits149: Glenmark Pharmaceuticals Ltd. - Key offerings
• Exhibits150: Merck KGaA - Overview
• Exhibits151: Merck KGaA - Business segments
• Exhibits152: Merck KGaA - Key news
• Exhibits153: Merck KGaA - Key offerings
• Exhibits154: Merck KGaA - Segment focus
• Exhibits155: Novartis AG - Overview
• Exhibits156: Novartis AG - Business segments
• Exhibits157: Novartis AG - Key offerings
• Exhibits158: Novartis AG - Segment focus
• Exhibits159: Novo Nordisk AS - Overview
• Exhibits160: Novo Nordisk AS - Business segments
• Exhibits161: Novo Nordisk AS - Key offerings
• Exhibits162: Novo Nordisk AS - Segment focus
• Exhibits163: Pfizer Inc. - Overview
• Exhibits164: Pfizer Inc. - Product / Service
• Exhibits165: Pfizer Inc. - Key news
• Exhibits166: Pfizer Inc. - Key offerings
• Exhibits167: Sanofi SA - Overview
• Exhibits168: Sanofi SA - Business segments
• Exhibits169: Sanofi SA - Key news
• Exhibits170: Sanofi SA - Key offerings
• Exhibits171: Sanofi SA - Segment focus
• Exhibits172: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibits173: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibits174: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibits175: Takeda Pharmaceutical Co. Ltd. - Key offerings
• Exhibits176: Tonghua Dongbao Pharmaceutical Co. Ltd. - Overview
• Exhibits177: Tonghua Dongbao Pharmaceutical Co. Ltd. - Product / Service
• Exhibits178: Tonghua Dongbao Pharmaceutical Co. Ltd. - Key offerings
• Exhibits179: Inclusions checklist
• Exhibits180: Exclusions checklist
• Exhibits181: Currency conversion rates for US$
• Exhibits182: Research methodology
• Exhibits183: Validation techniques employed for market sizing
• Exhibits184: Information sources
• Exhibits185: List of abbreviations